サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1719122

血液ろ過・浄化市場- 世界の産業規模、シェア、動向、機会、予測、製品別、用途別、エンドユーザー別、地域別、競争別、2020-2030F

Blood Filtration and Purification Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 182 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

血液ろ過・浄化市場- 世界の産業規模、シェア、動向、機会、予測、製品別、用途別、エンドユーザー別、地域別、競争別、2020-2030F
出版日: 2025年04月30日
発行: TechSci Research
ページ情報: 英文 182 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血液ろ過・浄化の世界市場は、2024年に38億1,000万米ドルと評価され、2030年には58億2,000万米ドルに達すると予測され、予測期間中のCAGRは7.29%で成長します。

この市場は、慢性疾患や血液関連疾患の有病率の増加に加え、臨床現場における高度なろ過技術に対する意識の高まりにより急速に拡大しています。血液浄化技術は、敗血症、慢性腎臓病、各種感染症などの疾患管理に不可欠であり、現代のヘルスケア提供に欠かせないものとなっています。マイクロ・ナノろ過システムの技術革新は治療の効率と精度を向上させ、外科手術の増加により病院、診断ラボ、診療所での製品需要がさらに高まっています。さらに、ヘルスケア支出の増加と自動化されたAI統合型ろ過システムの採用は、処置の合理化と患者の転帰の改善に役立っています。進化する医療ニーズに対応するために先進技術を採用するヘルスケアプロバイダーが増えるにつれて、血液ろ過・浄化市場は安定した成長を遂げようとしています。

市場概要
予測期間 2026-2030
市場規模：2024年 38億1,000万米ドル
市場規模：2030年 58億2,000万米ドル
CAGR：2025年～2030年 7.29%
急成長セグメント 遺伝子・分子診断薬
最大市場 北米

市場促進要因

慢性疾患の発生率の上昇

主な市場課題

高度ろ過装置のコスト高

主要市場動向

血液ろ過治療の個別化

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の血液ろ過・浄化市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 製品別（ろ過キットおよび試薬、膜、フィルターおよび消耗品、サンプル調製システム、特殊アッセイおよびカラム）
    • 用途別（感染症診断、毒物学および免疫診断、がん診断、遺伝子/分子診断、その他）
    • エンドユーザー別（臨床診断ラボ、病院、調査・学術機関、その他）
    • 企業別（2024）
    • 地域別
  • 市場マップ

第6章 北米の血液ろ過・浄化市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の血液ろ過・浄化市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の血液ろ過・浄化市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の血液ろ過・浄化市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの血液ろ過・浄化市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Thermo Fischer Scientific
  • MilliporeSigma
  • Roche lifescience
  • Sigma Aldrich
  • Avantor
  • Takara Bio
  • MP Biomedicals.
  • QIAGEN N.V
  • HiMedia
  • Biotage

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 28599

The Global Blood Filtration and Purification Market was valued at USD 3.81 Billion in 2024 and is projected to reach USD 5.82 Billion by 2030, growing at a CAGR of 7.29% during the forecast period. This market is expanding rapidly due to the increasing prevalence of chronic and blood-related conditions, coupled with growing awareness of advanced filtration technologies in clinical settings. Blood purification technologies are essential in the management of diseases such as sepsis, chronic kidney disease, and various infections, making them critical to modern healthcare delivery. Innovations in micro- and nano-filtration systems have enhanced the efficiency and precision of treatment, while the rising number of surgical interventions has further fueled product demand across hospitals, diagnostic labs, and clinics. Additionally, higher healthcare spending and the adoption of automated, AI-integrated filtration systems are helping streamline procedures and improve patient outcomes. As more healthcare providers adopt advanced technologies to meet evolving medical needs, the market for blood filtration and purification is poised for steady growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.81 Billion
Market Size 2030USD 5.82 Billion
CAGR 2025-20307.29%
Fastest Growing SegmentGenetic/Molecular Diagnostics
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Chronic Diseases

The growing burden of chronic diseases globally is a key factor driving the Blood Filtration and Purification Market. Conditions such as chronic kidney disease (CKD), diabetes, cardiovascular diseases (CVDs), and autoimmune disorders are increasingly common, resulting in a heightened need for filtration therapies. Over 850 million people suffer from CKD, which often requires dialysis-a treatment dependent on blood purification systems. Similarly, with approximately 830 million people living with diabetes as of 2022, diabetic nephropathy is rising, increasing the demand for blood filtration devices. Cardiovascular diseases, responsible for 17.9 million deaths annually, often lead to fluid overload and toxin buildup, necessitating blood purification treatments. Moreover, autoimmune diseases like rheumatoid arthritis can cause systemic issues, requiring therapies to filter harmful antibodies. With aging populations and growing disease prevalence, the demand for advanced blood purification technologies continues to surge globally.

Key Market Challenges

High Costs of Advanced Filtration Devices

The adoption of advanced blood filtration technologies is limited by the high cost of devices and associated maintenance. These systems often utilize specialized membranes, smart sensors, and integrated AI functionalities, increasing manufacturing and operational expenses. Such high-cost technologies are out of reach for many smaller healthcare providers, especially in developing economies. Additionally, reimbursement gaps in various healthcare systems create financial uncertainty, deterring investment in premium filtration solutions. With limited insurance coverage and minimal government subsidies, the return on investment for hospitals remains a concern. Furthermore, supply chain limitations and high costs of sourcing raw materials hinder affordability. These cost-related barriers not only restrict access but also slow the broader adoption of advanced blood purification across global markets.

Key Market Trends

Personalization of Blood Filtration Treatments

The blood filtration landscape is evolving toward personalized treatment approaches, supported by real-time diagnostics and AI-driven clinical decision-making. Healthcare providers are increasingly customizing filtration therapies based on patient-specific data, including biomarker levels, comorbid conditions, and treatment responses. This trend is especially prevalent in critical care environments where rapid and precise intervention is essential. AI and machine learning tools are now being used to adjust filtration parameters dynamically, enhancing treatment outcomes and minimizing side effects. Biosensor integration and wearable monitoring technologies are also contributing to this shift, enabling continuous patient evaluation and better decision-making. Manufacturers are responding by introducing modular systems and patient-tailored filtration kits. As the healthcare system increasingly emphasizes individualized, outcome-focused care, the trend toward personalized blood purification is expected to become mainstream in both acute and chronic care settings.

Key Market Players

  • Thermo Fischer Scientific
  • MilliporeSigma
  • Roche lifescience
  • Sigma Aldrich
  • Avantor
  • Takara Bio
  • MP Biomedicals
  • QIAGEN N.V
  • HiMedia
  • Biotage

Report Scope

In this report, the Global Blood Filtration and Purification Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Filtration and Purification Market, By Product:

  • Filtration Kits and Reagents
  • Membranes, Filters and Consumables
  • Sample Preparation Systems
  • Specialty Assays and Columns

Blood Filtration and Purification Market, By Application:

  • Infectious Disease Diagnostics
  • Toxicology and Immunodiagnostics
  • Cancer Diagnostics
  • Genetic/Molecular Diagnostics
  • Others

Blood Filtration and Purification Market, By End User:

  • Clinical Diagnostic Labs
  • Hospitals
  • Research and Academic Institutes
  • Others

Blood Filtration and Purification Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Filtration and Purification Market.

Available Customizations

Global Blood Filtration and Purification Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Blood Filtration and Purification Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Filtration Kits and Reagents, Membranes, Filters and Consumables, Sample Preparation Systems, Specialty Assays and Columns)
    • 5.2.2. By Application (Infectious Disease Diagnostics, Toxicology and Immunodiagnostics, Cancer Diagnostics, Genetic/Molecular Diagnostics, Others)
    • 5.2.3. By End User (Clinical Diagnostic Labs, Hospitals, Research and Academic Institutes, Others)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Blood Filtration and Purification Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Filtration and Purification Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Mexico Blood Filtration and Purification Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Canada Blood Filtration and Purification Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Blood Filtration and Purification Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Blood Filtration and Purification Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Blood Filtration and Purification Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Blood Filtration and Purification Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Blood Filtration and Purification Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Blood Filtration and Purification Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Blood Filtration and Purification Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Blood Filtration and Purification Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Blood Filtration and Purification Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. South Korea Blood Filtration and Purification Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Japan Blood Filtration and Purification Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Blood Filtration and Purification Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Blood Filtration and Purification Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Blood Filtration and Purification Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Blood Filtration and Purification Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Blood Filtration and Purification Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Blood Filtration and Purification Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Blood Filtration and Purification Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Blood Filtration and Purification Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Blood Filtration and Purification Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Thermo Fischer Scientific
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. MilliporeSigma
  • 14.3. Roche lifescience
  • 14.4. Sigma Aldrich
  • 14.5. Avantor
  • 14.6. Takara Bio
  • 14.7. MP Biomedicals.
  • 14.8. QIAGEN N.V
  • 14.9. HiMedia
  • 14.10. Biotage

15. Strategic Recommendations

16. About Us & Disclaimer